UKPOL.CO.UK

Tag: Parliamentary Question

  • Martyn Day – 2016 Parliamentary Question to the Ministry of Justice

    Martyn Day – 2016 Parliamentary Question to the Ministry of Justice

    The below Parliamentary question was asked by Martyn Day on 2016-01-20.

    To ask the Secretary of State for Justice, what plans the Government has to seek legislative consent from the Scottish Parliament for the proposed repeal of the Human Rights Act 1998.

    Dominic Raab

    This Government was elected with a clear mandate to replace the Human Rights Act with a Bill of Rights. We will bring forward proposals for consultation in due course, and will fully engage with the Devolved Administrations.

    It would be premature to comment on the application of the Sewell Convention until the package of legislation is settled.

  • David Simpson – 2016 Parliamentary Question to the Department of Health

    David Simpson – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by David Simpson on 2016-02-11.

    To ask the Secretary of State for Health, what recent assessment his Department has made of the potential benefits of talking therapy for the treatment of mental health.

    Alistair Burt

    The Improving Access to Psychological Therapies (IAPT) programme is a National Institute for Health and Care Excellence recommend evidence based intervention, helping adults with common mental health conditions (including anxiety and depression) to recover. The latest data shows that that nationally we are achieving a 45% recovery rate and 61% rate in reliable improvement. In total over 733,000 people have recovered from their condition since the start of the IAPT programme, and between October 2008 and February 2015 over 100,000 people moved off of sick pay and benefits.

    The Impact Assessment published in 2011 shows that the IAPT programme would expect to deliver improved health and wellbeing of those treated, as well as savings to the National Health Service and wider economic benefits such as reductions in sickness absence.

  • Catherine McKinnell – 2016 Parliamentary Question to the Home Office

    Catherine McKinnell – 2016 Parliamentary Question to the Home Office

    The below Parliamentary question was asked by Catherine McKinnell on 2016-03-03.

    To ask the Secretary of State for the Home Department, what plans the Government has to contribute to an international framework for the sharing of communications data; and if she will make a statement.

    Mr John Hayes

    The UK and United States Governments have begun considering a framework under which US-based communication service providers could disclose data directly for serious criminal and counter terrorism investigations, in response to a warrant requesting the content of communications, and with notices requiring the disclosure of communications data.

    This builds on the work of the Prime Minister’s Special Envoy on Intelligence and Law Enforcement Data Sharing; the recommendation of the Independent Reviewer of Terrorism Legislation; and the recommendations of the Joint Committee on the draft Investigatory Powers Bill, that the UK develop a framework for accessing data across jurisdictions.

  • Baroness Masham of Ilton – 2016 Parliamentary Question to the HM Treasury

    Baroness Masham of Ilton – 2016 Parliamentary Question to the HM Treasury

    The below Parliamentary question was asked by Baroness Masham of Ilton on 2016-04-12.

    To ask Her Majesty’s Government what assessment they have made of the associated health benefits of some sweetened fruit juices, and of the impact of the sugar levy on sweetened fruit juices with such associated health benefits.

    Lord O’Neill of Gatley

    The new soft drinks industry levy does not target pure fruit juices where no sugar is added. Fruit juices are part of the 5-a-day message as they have intrinsic nutrients and other health benefits.

    Juice drinks with added sugar are in the scope of the levy because they can be reformulated and/or sweetened with less caloric sweeteners providing the same vitamins and health benefits without the added sugar.

  • Cat Smith – 2016 Parliamentary Question to the Department of Health

    Cat Smith – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Cat Smith on 2016-05-05.

    To ask the Secretary of State for Health, what steps he is taking to monitor the effectiveness of the Medicines and Healthcare Products Regulatory Agency toolkit on the risks of valproate medicines in female patients in ensuring that female patients are better informed about the risks of taking valproate medicines during pregnancy.

    George Freeman

    Valproate is an effective treatment for epilepsy and bipolar disorder but should only be used in girls and women of childbearing potential if other treatments are ineffective or not tolerated. For some women there may be no other treatment option. Since it was authorised, valproate was known to have risks in pregnancy. Because of ongoing concerns about women’s awareness of the risks, the Medicines and Healthcare products Regulatory Agency (MHRA) has worked with professional bodies, voluntary organisations and patient groups to develop a set of materials to aid communication between health professionals and women and girls.

    The valproate toolkit comprises booklets for healthcare professionals, a reminder card and a guide for women, a checklist for prescribers and clear package labelling carrying a prominent warning about use in pregnancy. It was widely disseminated on 8 February 2016 through a Central Alerting System (a web based cascade system for issuing alerts to the National Health Service) and the MHRA’s Drug Safety Update bulletin. Electronic copies of the toolkit are hosted on several websites including the Electronic Medicines Compendium. Letters and hard copies of the toolkit were sent by the marketing authorisation holder directly to general practitioners (GPs), pharmacists and relevant specialists. This included 400,000 patient cards, 81,000 patient guides and 22,000 healthcare professional booklets.

    In order to monitor the effectiveness of the valproate toolkit, the MHRA has sought feedback from all stakeholders and will continue to work with the Royal Colleges, professional bodies including the Royal Pharmaceutical Society, patient groups and relevant charities to increase awareness of the toolkit among GPs, pharmacists and patients.This work will include exploring how clinical commissioning groups can help ensure the toolkit materials are being used.

    So far, the MHRA has worked with voluntary organisations and patient groups to produce online patient surveys to measure awareness of the risks among patients. Furthermore, MHRA is conducting a study using the Clinical Practice Research Datalink to track changes in prescribing of valproate to women and girls following the communications to healthcare professionals and patients on the risks of valproate in pregnancy. The marketing authorisation holder is conducting Europe-wide studies to measure the changes in patterns of prescribing and awareness of the healthcare professionals of the risks. The available data will be brought together in a regularly updated dashboard that will be used to track the impact of the communications on patient and professional awareness over time.

    The Government has great sympathy for those families who have been affected by the use of valproate in pregnancy. There is support available for families with children born with a disability. For many people this will involve an early intervention programme from health visitors and midwives, to help a child develop, as well as provide support to the family. This might include: speech and language therapy – to help with any problems communicating or feeding; physiotherapy – to help with any muscle weakness or movement difficulties, and individual home teaching programmes.

    Where a child has a special educational need the local authority must make support available to ensure the child had access to the same educational opportunities as a child without such a need. The Children and Families Act 2014 introduced a new statutory framework for local authorities and to work together to secure services for children and young people – up to the age of 25 – who have special educational needs or disability, across education, health and social care.

    The MHRA’s current priority is to work to ensure that women taking valproate are fully aware of the risks in pregnancy. Once this is achieved we will look into the history of the episode and see what lessons have been or could be usefully learnt by examining events.

  • Roger Godsiff – 2016 Parliamentary Question to the Home Office

    Roger Godsiff – 2016 Parliamentary Question to the Home Office

    The below Parliamentary question was asked by Roger Godsiff on 2016-06-27.

    To ask the Secretary of State for the Home Department, what estimate her Department has made of the potential costs of compliance with measures contained in the Investigatory Powers Bill to (a) the public purse and (b) private companies.

    Mr John Hayes

    The majority of the powers in the Investigatory Powers Bill already exist and will not incur additional costs. The Bill makes a new provision for the retention of additional data, known as internet connection records, by domestic Communications Service Providers who are under a data retention notice, to ensure that law enforcement continue to have the powers they need to acquire communications data as threats change and technology develops.

    The Government’s overall published estimate of the costs associated with the Investigatory Powers Bill is £247 million. This includes costs associated with increased compliance and authorisation of warrantry and costs to the justice system for offences and changes to the Investigatory Powers Tribunal. These are set out in the Overarching Impact Assessment published on 4 November.

  • Lord Mawhinney – 2016 Parliamentary Question to the Department for Exiting the European Union

    Lord Mawhinney – 2016 Parliamentary Question to the Department for Exiting the European Union

    The below Parliamentary question was asked by Lord Mawhinney on 2016-09-14.

    To ask Her Majesty’s Government whether they envisage any form of public consultation before they decide their negotiating position, once Article 50 has been invoked, on those relationships with Ireland that fall outside EU competence.

    Lord Bridges of Headley

    The Department for Exiting the EU will be conducting the UK’s negotiations to leave the European Union in support of the Prime Minister. We will be working closely with Parliament, devolved administrations, and a wide range of other interested parties.

    Our relationship with Ireland is unique and we have already engaged extensively with Northern Ireland and the Republic of Ireland. The Prime Minister and the Taoiseach met in London on 26 July and the Secretary of State for Exiting the EU visited both Belfast and Dublin in early September to engage with government and business stakeholders.

    We look forward to working closely with the Irish Government and other key stakeholders as we develop our approach, and to make the most of the opportunities for both countries.

  • Mark Williams – 2015 Parliamentary Question to the Wales Office

    Mark Williams – 2015 Parliamentary Question to the Wales Office

    The below Parliamentary question was asked by Mark Williams on 2015-11-10.

    To ask the Secretary of State for Wales, on what grounds the decision was taken to refuse Crown consent for provisions within the Environment Bill currently passing through the Welsh Assembly.

    Stephen Crabb

    The Welsh Government has sought the consent of the Secretary of State to impose the biodiversity duty in the Environment (Wales) Bill on Ministers of the Crown. This request is the subject of ongoing discussions between the UK Government and the Welsh Government.

  • Luciana Berger – 2015 Parliamentary Question to the Department of Health

    Luciana Berger – 2015 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Luciana Berger on 2015-12-09.

    To ask the Secretary of State for Health, if he will make it his policy to collect information centrally on the proportion of people who received consultant-led mental health treatment within 18 weeks of referral.

    Alistair Burt

    We are implementing the first access and waiting times standards for mental health to ensure that 75% of people referred to the Improving Access to Psychological Therapies (IAPT) programme will be treated within six weeks of referral, and 95% will be treated within 18 weeks of referral and that 50% of people experiencing a first episode of psychosis will be treated with a National Institute for Health and Care Excellence approved care package within two weeks of referral.

    NHS England already collects data on waiting times for people referred to IAPT services.

    We are working with the Health and Social Care Information Centre and NHS England to make changes to the Mental Health and Learning Disabilities Dataset to start collecting data for the first time to measure, in a consistent way, access and waiting times for people referred to other mental health services. We will start collecting data first on access and waiting times for people referred for treatment following a first episode of psychosis in early 2016 and intend expanding this to other areas of mental health later.

  • Lord Hunt of Kings Heath – 2016 Parliamentary Question to the Department of Health

    Lord Hunt of Kings Heath – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Lord Hunt of Kings Heath on 2016-01-19.

    To ask Her Majesty’s Government, in the light of the planned replacement of student bursaries by loans, how many nurse placements will be funded by Health Education England in 2017–18.

    Lord Prior of Brampton

    It is not possible to determine these numbers at this stage as these will be based on the Health Education England (HEE) workforce plan, which is completed annually ahead of each student intake. HEE will continue to have a key leading role in the commissioning of nursing, midwifery and allied health courses. It will continue to provide sufficient clinical placement funding for those places needed to meet the workforce planning needs of the National Health Service.